ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study

NCT04431258 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: ABTL0812
DRUG: Folfirinox
DRUG: Placebo

Sponsor

Ability Pharmaceuticals SL